|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.319
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.311
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.265
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.265
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.224
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.224
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.206
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.190
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.177
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.174
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.169
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.167
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.159
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.156
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.155
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.139
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.138
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.131
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.129
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.128
|
|
|
|
dna methylation involved in gamete generation
|
GO:0043046 |
15 |
0.127
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.124
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.124
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.121
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.120
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.117
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.116
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.114
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.112
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.112
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.110
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.106
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.105
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.104
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.104
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.103
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.102
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.101
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.101
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.100
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.098
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.098
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.097
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.095
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.093
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.090
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.090
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.088
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.086
|
|
|
|
menarche
|
GO:0042696 |
1 |
0.085
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.084
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.082
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.082
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.081
|
|
|
|
cerebral cortex neuron differentiation
|
GO:0021895 |
19 |
0.080
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.078
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.078
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.077
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.075
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.073
|
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.071
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.070
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.068
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.067
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.064
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.064
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.064
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.064
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.063
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.063
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.062
|
|
|
|
globus pallidus development
|
GO:0021759 |
2 |
0.062
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.062
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.060
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.060
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.060
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.060
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.059
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.059
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.059
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.058
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.058
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.057
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.057
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.057
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.057
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.056
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.056
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.055
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.055
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.054
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.054
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.054
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.053
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.053
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.052
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.052
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.052
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.051
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.051
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.051
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.051
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.050
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.050
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.050
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.050
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.050
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.050
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.050
|
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.049
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.049
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.049
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.048
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.048
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.047
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.047
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.047
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.047
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.046
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.046
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.046
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.046
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.046
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.045
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.045
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.045
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.045
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.045
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.045
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.045
|
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.045
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.045
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.045
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.045
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.045
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.045
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.044
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.044
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.044
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.044
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.043
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.043
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.042
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.042
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.042
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.042
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.041
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.041
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.041
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.041
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.041
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.041
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.041
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.041
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.041
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.041
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.041
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.040
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.040
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.040
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.039
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.039
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.039
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.038
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.038
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.038
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.038
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.038
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.038
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.038
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.038
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.037
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.037
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.037
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.037
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.036
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.035
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.035
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.035
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.035
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.035
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.034
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.034
|
|
|
|
atrioventricular node cell development
|
GO:0060928 |
2 |
0.034
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.034
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.034
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.034
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.034
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.034
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.033
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.033
|
|
|
|
metanephric dct cell differentiation
|
GO:0072240 |
3 |
0.033
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.033
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.033
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.033
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.033
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.033
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.032
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.032
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.032
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.032
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.032
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.032
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.032
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.032
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.032
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.032
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.032
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.031
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.031
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.031
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.031
|
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.031
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.031
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.031
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.031
|
|
|
|
regulation of ureteric bud formation
|
GO:0072106 |
3 |
0.031
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.030
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.030
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.030
|
|
|
|
paraxial mesoderm development
|
GO:0048339 |
18 |
0.030
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.030
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.029
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.029
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.029
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.029
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.029
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.029
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.029
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.029
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.029
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.029
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.029
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.029
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.028
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.028
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.028
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.028
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.028
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.028
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.028
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.028
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.028
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.028
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.028
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.028
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.028
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.028
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.028
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.028
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.028
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.028
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.027
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.027
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.027
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.027
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.027
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.027
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
15 |
0.027
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.027
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.027
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.027
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.027
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.026
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.026
|
|
|
|
response to pain
|
GO:0048265 |
26 |
0.026
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.026
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.026
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.026
|
|
|
|
type b pancreatic cell fate commitment
|
GO:0003327 |
1 |
0.026
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.026
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.026
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.026
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.026
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.025
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.025
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.025
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.025
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.025
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.025
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.025
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.025
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.025
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.025
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.025
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.025
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.025
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.024
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.024
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.024
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.024
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.024
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.024
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.024
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.024
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.024
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.024
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.024
|
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.024
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.024
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.024
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.024
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.024
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.024
|
|
|
|
cerebral cortex gabaergic interneuron differentiation
|
GO:0021892 |
9 |
0.024
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.024
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.023
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.023
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
18 |
0.023
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.023
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.023
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.023
|
|
|
|
negative regulation of fibroblast growth factor production
|
GO:0090272 |
2 |
0.023
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.023
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.023
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.023
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.023
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.023
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.022
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.022
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.022
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.022
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.022
|
|
|
|
germline stem cell asymmetric division
|
GO:0098728 |
2 |
0.022
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.022
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.022
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.022
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.022
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.022
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.022
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.022
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.022
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.021
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.021
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.021
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.021
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.021
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.021
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.021
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.021
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.021
|
|
|
|
regulation of axon diameter
|
GO:0031133 |
6 |
0.021
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.021
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.021
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.021
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.021
|
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
16 |
0.021
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.021
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.021
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.021
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.021
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.021
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.021
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.021
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.020
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.020
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.020
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.020
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.020
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.020
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.020
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.020
|
|
|
|
positive regulation of dna templated transcription initiation
|
GO:2000144 |
5 |
0.020
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.020
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.020
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.020
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.020
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.020
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.020
|
|
|
|
natural killer cell chemotaxis
|
GO:0035747 |
1 |
0.020
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.020
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.020
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.020
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.020
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.020
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.019
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.019
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.019
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.019
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.019
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.019
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.019
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.019
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.019
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.019
|
|
|
|
nephric duct elongation
|
GO:0035849 |
1 |
0.019
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.019
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.019
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.019
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.019
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.019
|
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.019
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.019
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.019
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.018
|
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.018
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.018
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.018
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.018
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.018
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.018
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.018
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.018
|
|
|
|
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0072108 |
3 |
0.018
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.018
|
|
|
|
middle ear morphogenesis
|
GO:0042474 |
23 |
0.018
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.018
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.018
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.018
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.018
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.018
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.018
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.018
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.018
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.018
|
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
2 |
0.018
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.018
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.017
|
|
|
|
positive regulation of meiosis i
|
GO:0060903 |
5 |
0.017
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.017
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
19 |
0.017
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.017
|
|
|
|
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0003339 |
5 |
0.017
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.017
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.017
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.017
|
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.017
|
|
|
|
metanephric thick ascending limb development
|
GO:0072233 |
2 |
0.017
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.017
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.017
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900212 |
4 |
0.017
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.017
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.017
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.017
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.017
|
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.017
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.017
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.017
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.016
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.016
|
|
|
|
proton transport
|
GO:0015992 |
35 |
0.016
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.016
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.016
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.016
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.016
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.016
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.016
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.016
|
|
|
|
positive regulation of granulocyte macrophage colony stimulating factor production
|
GO:0032725 |
3 |
0.016
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.016
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.016
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900211 |
4 |
0.016
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.016
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.016
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.016
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.016
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.016
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.016
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.016
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.016
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.016
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.016
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.016
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.016
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.016
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.016
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.016
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.016
|
|
|
|
granulocyte macrophage colony stimulating factor production
|
GO:0032604 |
3 |
0.016
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.016
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.015
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.015
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.015
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.015
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.015
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.015
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.015
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.015
|
|
|
|
regulation of anterior head development
|
GO:2000742 |
2 |
0.015
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.015
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.015
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.015
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.015
|
|
|
|
tachykinin receptor signaling pathway
|
GO:0007217 |
1 |
0.015
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.015
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.015
|
|
|
|
renal vesicle development
|
GO:0072087 |
17 |
0.015
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.015
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.015
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.015
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.015
|
|
|
|
motor neuron migration
|
GO:0097475 |
4 |
0.015
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.015
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.015
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.015
|
|
